Howard Chang, Senior VP of Global Research & Chief Scientific Officer at Amgen — Verified Quotes & Interview Transcripts

Recent appearances

The Lurie Prize In Biomedical Sciences 2024 Award: Dr. Howard Y. Chang

October 30, 2024 · 📺 Foundation for the National Institutes of Health

The Foundation for the National Institutes of Health (FNIH) has named Howard Y. Chang, M.D., Ph.D., of Stanford University, as the recipient of the 2024 Lurie Prize in Biomedical Sciences. Dr. Chang and his team revealed the vital importance of long noncoding RNA – genetic material that does not code for proteins – in gene regulation and its impact on human diseases, including cancer and autoimmunity. Learn more: https://fnih.org/our-programs/powerin...

Watch on YouTube ↗
QB3 Webinar: Howard Chang, Stanford. "Personal Regulome Navigation of Cancer"

December 07, 2022 · 📺 QB3TV

Cancer is a disease of genes. Yet the elucidation of cancer genomes does not mean we have conquered cancer; the central challenge is in their interpretation. In every human cell, two meters of DNA is packed into a ~10 micron nucleus. The genome is extensively compacted, except for the active regulatory DNA elements that remain accessible. I will describe new technologies based on DNA transposition that reveal the epigenomic profiles of single cells or from clinical biopsies of disease states. The landscape of active DNA regulatory elements are further linked to 3D genome architecture, mutation…

Watch on YouTube ↗
CSHL Keynote; Dr. Howard Chang, Stanford University School of Medicine

May 24, 2022 · 📺 CSHL Leading Strand

"Genome regulation by long noncoding RNAs" from the Regulatory & Non-Coding RNAs meeting 5/17/2022 Attend a CSHL ...

Watch on YouTube ↗
Howard Chang (Stanford, HHMI) 3: LncRNA Function at the DNA Level: PVT1

January 28, 2020 · 📺 Science Communication Lab

https://www.ibiology.org/genetics-and-gene-regulation/epigenomics-lncrnas In this talk, Dr. Howard Chang describes epigenomic ...

Watch on YouTube ↗
Genome regulation by long noncoding RNAs

June 13, 2016 · 📺 NIH VideoCast

Genome regulation by long noncoding RNAs Air date: Wednesday, June 1, 2016, 3:00:00 PM Category: WALS - Wednesday Afternoon Lectures Runtime: 01:03:47 Description: NIH Director’s Wednesday Afternoon Lecture Series Dr. Chang’s research addresses how large sets of genes are turned on or off together, which is important in normal development, cancer, and aging. Chang discovered a new class of genes, termed long noncoding RNAs, can control gene activity throughout the genome, illuminating a new layer of biological regulation. He has invented new methods for defining the shapes of RNA and…

Watch on YouTube ↗
Dr. Howard Chang speaks at Canada Gairdner Symposium: RNA and the New Genetics

November 24, 2015 · 📺 CanadaGairdnerAwards

Dr. Chang spoke at the Canada Gairdner Symposium at the University of Toronto about his work on noncoding RNA.

Watch on YouTube ↗
Dr. Chang on the TRINOVA-1 Trial in Ovarian Cancer

June 25, 2013 · 📺 OncLive

David D. Chang, MD, PhD, head of global oncology development at Amgen, discusses the design of the TRINOVA-1 trial in ...

Watch on YouTube ↗
Howard Chang, recipient of The Vilcek Prize for Creative Promise in Biomedical Science in 2009

April 22, 2011 · 📺 The Vilcek Foundation

An interview with Howard Chang, recipient of The 2009 Vilcek Prize for Creative Promise in Biomedical Science. The Vilcek Prize for Creative Promise recognizes foreign-born artists and scientists who have demonstrated exceptional creativity and originality in the early stages of their careers. Two $25,000 prizes, one in the field of biomedical science and one in a category of the arts or humanities designated by the Foundation, are awarded each year. For more information, please visit www.vilcek.org

Watch on YouTube ↗

Other executives at Amgen

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →

Recent appearances

Other executives at Amgen

Keep reading the full archive